There isn’t a single “semaglutide patent” expiration date. Semaglutide is protected by multiple patent families covering different things, and those patents expire at different times depending on the country and the type of protection (the molecule itself, formulations, methods of use, delivery devices, etc.).
If you want a precise date, I’ll need a bit more detail:
- Which jurisdiction(s) are you interested in (e.g., United States, European Union, Japan, or worldwide)?
- Are you asking about the active ingredient (the semaglutide molecule) or about a specific product/formulation (e.g., Ozempic injectable, Rybelsus oral tablet) or a delivery device?
- Do you want the expiry dates for the composition-of-matter patents only, or also for formulation/use patents and device patents?
What I can tell you at a high level:
- The molecule/active ingredient semaglutide is protected by multiple patent families. The core “composition of matter” patents for the molecule and related analogs exist in several jurisdictions and may expire around the late 2020s to early 2030s, depending on term adjustments and extensions.
- The oral formulation (semaglutide with SNAC, used for Rybelsus) has its own set of patents covering the SNAC-based absorption technology and formulation; those typically run into the early to mid-2030s in many markets.
- Patents covering injectable formulations (Ozempic), dosing devices/pens, and methods of use (e.g., treating diabetes or obesity with semaglutide) add additional expiration dates.
- In addition to patents, there are regulatory data exclusivity provisions in some jurisdictions that can delay generic entry even after patent expiry.
If you want, I can help you locate the exact expiration dates by jurisdiction and patent family. Just tell me:
- the jurisdiction(s)
- whether you want the molecule patent(s) only or all relevant patents (molecule, formulations, devices, and uses)
I can then outline the specific patent numbers and their listed expiration dates from public sources like Google Patents, Espacenet, and the USPTO/EPO databases.